Clozapine metabolism rate as a possible index of drug-induced granulocytopenia

Psychopharmacology

Volumn 137, Issue 4, 1998, Pages 341-344

  Mauri, M C ^a   Rudelli, R ^a   Bravin, S ^a   Gianetti, S ^a   Giuliani, E ^b   Guerrini, A ^b   Orlandi, R ^c   Invernizzi, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b GENERAL HOSPITAL   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Clozapine; Granulocytopenia; Metabolism

Indexed keywords

CLOZAPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; GRANULOCYTOPENIA; HUMAN; LEUKOCYTE COUNT; MALE; NEUTROPHIL; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RISK FACTOR; SCHIZOPHRENIA;

ADULT; AGRANULOCYTOSIS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; FEMALE; HUMANS; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MIDDLE AGED; RISK FACTORS; SCHIZOPHRENIA;

EID: 0031748033     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050628     Document Type: Article

References (15)

1. Alvir JMAJ, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA (1993) Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N Engl J Med 329:162-167
2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disease, 4th edn, DSM IV. American Psychiatric Association, Washington, DC
3. Arranz MJ, Dawson E, Shaikh S, Sharma T, Aitchison K, Croq MA, Gill M, Kerwin R, Collier DA (1995) Cytochrome P450IID6 genotype does not determine response to clozapine. Schizophr Res 15:35
4. Centorrino F, Baldessarini RJ, Kando JC, Frankenburg FR, Volpicelli SA, Flood JG (1994) Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients. J Clin Psychopharmacol 14:119-125
5. Centorrino F, Baldessarini RJ, Flood JG, Kando JC, Frankenburg FR (1995) Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine metabolites. Am J Psychiatry 152:610-612
6. Dahl ML, Llerena A, Bondesson U, Lindström L, Bertilsson L (1994) Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphisms. Br J Clin Pharmacol 37:71-74
7. Fischer V, Haar JA, Greiner L, Lloyd RV, Mason RP (1991) Possible role of free radical formation in clozapine (Clozaril)-induced agranulocytosis. Mol Pharmacol 40:846-853
8. Gerson SL, Arce C, Meltzer HY (1994) N-Desmethylclozapine: a clozapine metabolite that suppresses haemopoiesis. Br J Haematol 86:555-561
9. Humpel C, Haring C, Saria A (1989) Rapid and sensitive determination of clozapine in human plasma using high performance liquid chromatography and amperometric detection. J Chromatogr 491:235-239
10. Jann MW, Grimsley SR, Gray EC, Chang Wen-Ho (1993) Pharmacokinetics and pharmacodynamics of clozapine. Clin Pharmacokinet 24:161-176
11. Kronig MH, Munne RA, Szymanski S, Safferman AZ, Pollack S, Cooper T, Kane JM, Lieberman JA (1995) Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients. Am J Psychiatry 152:179-182
12. Krupp P, Barnes P (1989) Leponex-associated granulocytopenia: a review of the situation. Psychopharmacology 99:S118-S121
13. Lieberman JA, Yunis J, Egea H, Canoso RT, Kane JM, Yunis EJ (1990) HLA-B38, DR4, DQw3 and dozapine-induced agranulocytosis in Jewish patients with schizophrenia. Arch Gen Psychiatry 47: 945-948
14. Mauri MC, Giuliani E, Coppola MT, Sicaro A, Bravin S, Invernizzi G (1996) Plasma levels of clozapine and norclozapine in chronic schizophrenics. Eur Neuropsychopharmacol 6[3S]:4
15. Mendelowitz AJ, Gerson SL, Alvir JMAJ, Lieberman JA (1995) Clozapine-induced agranulocytosis. Risk factors, monitoring and management. CNS Drugs 4: 412-421